ACTIVE PHARMACEUTICAL INGREDIENT MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-61561 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Active Pharmaceutical Ingredient Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET

7.1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 BASF

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Teva

16.3 Sun Pharmaceutical Industries

16.4 Aurobindo pharma

16.5 Bayer

16.6 Johnson & Johnson

16.7 Jiangsu Hengrui Medicine

16.8 Dr Reddy's Laboratories

16.9 Cipla

16.10 Zhejiang Medicine

16.11 Haerbin Pharmaceutical Group

16.12 North East Pharmaceutical

16.13 Lupin

16.14 Tian Yao

16.15 Cambrex

16.16 Mylan

16.17 Hisun Pharmacy

16.18 Biocon

16.19 North China Pharmaceutical Group

16.20 Roche

16.21 Novartis

16.22 Huahai Pharmaceutical

16.23 Boehringer Ingelheim GmbH

16.24 Albemarle

16.25 Lonza group

16.26 Johnson Matthey

16.27 Shandong Lukang Pharmaceutical

16.28 Bachem

16.29 DSM

16.30 Shandong Xinhua Pharmaceutical

16.31 Pfizer

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Biotech API
Synthetic API
Others

By Application
Anti-diabetic Drugs
Oncology Drugs
Non-steroidal Anti-inflammatory Drugs (NSAIDs)

Companies

BASF
Teva
Sun Pharmaceutical Industries
Aurobindo pharma
Bayer
Johnson & Johnson
Jiangsu Hengrui Medicine
Dr Reddy's Laboratories
Cipla
Zhejiang Medicine
Haerbin Pharmaceutical Group
North East Pharmaceutical
Lupin
Tian Yao
Cambrex
Mylan
Hisun Pharmacy
Biocon
North China Pharmaceutical Group
Roche
Novartis
Huahai Pharmaceutical
Boehringer Ingelheim GmbH
Albemarle
Lonza group
Johnson Matthey
Shandong Lukang Pharmaceutical
Bachem
DSM
Shandong Xinhua Pharmaceutical
Pfizer

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.